Fundraising Fox
/Companies
Sign in

Renovo Concepts

San Antonio, US · Founded 2016 · Delaware corporation · 1 known investors

Find your way into Renovo Concepts

Sign up to see every warm intro you have to Renovo Concepts

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Renovo Concepts team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Renovo Concepts develops Mechanical Tissue Resuscitation (MTR), a therapy that applies controlled sub-atmospheric pressure to remove excess fluid from damaged brain, heart, and spinal tissue in order to reduce secondary injury. Its first clinical indication is traumatic brain injury, and the company is conducting first-in-human clinical trials.

BiotechHealthtechMedical Devices

Founders & leadership

MMMichael Morykwas
Michael MorykwasCo-inventor of MTR
LLLinda Loftus
Linda LoftusTreasurer and Secretary
LALouis Argenta
Louis ArgentaCo-inventor of MTR
SV
Silbiano V. Gonzales, Jr.Named on SEC filing
CI
Charles I. Biltz, Jr.Named on SEC filing
FD
Frank DilazzaroNamed on SEC filing

Board

WM
William MayerBoard director
ML
Martin LandonBoard director

Investors · 1

Also in the syndicate · 1

San Antonio Military Medical Innovation (SAMMI) Fund

Funding

SEC filings, press & company announcements

$12M disclosed across 7 of 9 rounds · 2018–2023

  • Undisclosed amountseries AJun 2021 · 3 sources
    Source ↗
  • Undisclosed amountSeries AApr 2021

    San Antonio Military Medical Innovation (SAMMI) Fund

    Source ↗
▶$8.1MraisedSep 2026 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter ArgentaDirector
  • Michael MorykwasExecutive Officer, Director
  • William MayerDirector
  • Martin LandonDirector
  • Linda LoftusExecutive Officer
  • John A WilsonExecutive Officer
Offering amount
$10.1M
Amount sold
$8.1M
Minimum investment
$10K
Proceeds to insiders
$180K
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$420.1KraisedMay 2022 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael MorykwasDirector
  • Mark StandefordExecutive Officer, Director
  • Louis ArgentaDirector
  • William MayerDirector
  • Martin LandonDirector
Offering amount
$2M
Amount sold
$420.1K
First sale
May 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedJun 2020 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles I. Biltz, Jr.Executive Officer, Director
  • Martin J. LandonDirector
  • Houston CowanDirector
  • Louis ArgentaDirector
  • Michael MorykwasExecutive Officer, Director
  • Silbiano V. Gonzales, Jr.Executive Officer, Director
Offering amount
$10M
Amount sold
$1.3M
First sale
May 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$350KraisedMar 2020 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin J. LandonDirector
  • Charles I. Biltz, Jr.Executive Officer, Director
  • Louis ArgentaDirector
  • Silbiano V. Gonzales, Jr.Executive Officer, Director
  • Michael MorykwasExecutive Officer, Director
  • Houston CowanDirector
Offering amount
$700K
Amount sold
$350K
First sale
Feb 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$925KraisedSep 2019 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Silbiano V. Gonzales, Jr.Executive Officer, Director
  • Frank DilazzaroExecutive Officer, Director
  • Christopher FashekDirector
  • Michael MorykwasDirector
  • Charles I. Biltz, Jr.Executive Officer, Director
  • Louis ArgentaDirector
Offering amount
$3M
Amount sold
$925K
First sale
Sep 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedOct 2018 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Silbiano V. Gonzales, Jr.Executive Officer, Director
  • Michael MorykwasDirector
  • Charles I. Biltz, Jr.Executive Officer, Director
  • Louis ArgentaDirector
  • Frank DilazzaroExecutive Officer, Director
Offering amount
$1.8M
Amount sold
$400K
First sale
May 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedOct 2018 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank DilazzaroExecutive Officer, Director
  • Silbiano V. Gonzales, Jr.Executive Officer, Director
  • Louis ArgentaDirector
  • Michael MorykwasDirector
  • Charles I. Biltz, Jr.Executive Officer, Director
Offering amount
$500K
Amount sold
$500K
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Renovo RxRenovoRx is a life sciences company developing targeted drug delivery for cancer treatment, including its TAMP therapy approach. It operates as a publicly listed biopharmaceutical/medical device company focused on oncology.
LeadIQLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.

Companies working in the same space as Renovo Concepts.

In the news

Renovo Concepts, Inc. Announces FDA Approval of IDE for Phase I Clinical Trial Of Novel MTR Device for Treatment of Traumatic Brain Injuries — Renovo Concepts, Inc.renovoconcepts.com · Nov 2023

Frequently asked questions

What does Renovo Concepts do?
Renovo Concepts develops Mechanical Tissue Resuscitation (MTR), a therapy that applies controlled sub-atmospheric pressure to remove excess fluid from damaged brain, heart, and spinal tissue in order to reduce secondary injury. Its first clinical indication is traumatic brain injury, and the company is conducting first-in-human clinical trials.
How much funding has Renovo Concepts raised?
Renovo Concepts has disclosed $12M raised across 7 of its 9 known rounds.
Where is Renovo Concepts headquartered?
Renovo Concepts is headquartered in San Antonio, US.